| scholarly article | Q13442814 |
| P356 | DOI | 10.1191/0961203303LU1036OA |
| P698 | PubMed publication ID | 15303570 |
| P50 | author | Dafna D. Gladman | Q37605821 |
| P2093 | author name string | C A Pineau | |
| M B Urowitz | |||
| D Ibanez | |||
| P J Fortin | |||
| P2860 | cites work | Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis | Q28374385 |
| Involvement of ErbB-2 in rheumatoid synovial cell growth | Q32067910 | ||
| Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry | Q33562885 | ||
| Loss of bone mineral density in premenopausal women with systemic lupus erythematosus | Q33567190 | ||
| Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density | Q34536848 | ||
| Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls | Q35549109 | ||
| Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus | Q35549203 | ||
| Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone | Q37383855 | ||
| Trabecular and cortical bone loss in systemic lupus erythematosus | Q40949194 | ||
| The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus | Q40974327 | ||
| SLE and osteoporosis: dependence and/or independence on glucocorticoids | Q41066138 | ||
| Loss of trabecular bone mineral density in systemic lupus erythematosus | Q46793102 | ||
| Body composition in systemic lupus erythematosus. | Q53353450 | ||
| P433 | issue | 6 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| osteoporosis | Q165328 | ||
| P304 | page(s) | 436-441 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density | |
| P478 | volume | 13 |
| Q88364911 | Assessment of the risk of low bone mineral density in premenopausal Japanese female patients with systemic lupus erythematosus |
| Q36319630 | Bone health and systemic lupus erythematosus |
| Q48895837 | Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus. |
| Q51196776 | Children and adolescents with SLE: not just little adults. |
| Q37047867 | Chronic pediatric inflammatory diseases: effects on bone |
| Q37175331 | Effects of salvianolate on bone metabolism in glucocorticoid-treated lupus-prone B6.MRL-Fas (lpr) /J mice |
| Q38692553 | Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis |
| Q34394081 | Glucocorticoid-induced osteoporosis in rheumatic diseases |
| Q35920464 | Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process |
| Q48200863 | Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only |
| Q46158711 | Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids |
| Q46901557 | Modern therapy for systemic lupus erythematosus |
| Q37756576 | Osteoporosis and inflammation |
| Q92594493 | Osteoporosis in Systemic Lupus Erythematosus - Correlations with Disease Activity and Organ Damage |
| Q34192060 | Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators |
| Q33723511 | Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? |
| Q39492537 | Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus. |
| Q51139095 | Prevalence and associated factors of reduced bone mineral density in patients with idiopathic inflammatory myopathies. |
| Q42073555 | Prevalence and possible risk factors of low bone mineral density in untreated female patients with systemic lupus erythematosus |
| Q51597128 | Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus. |
| Q33727015 | Rheumatic autoimmune diseases in women and midlife health |
| Q44498317 | Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus |
| Q53100421 | SLE disease per se contributes to deterioration in bone mineral density, microstructure and bone strength. |
| Q49835275 | Systemic lupus erythematosus patients with high disease activity are associated with accelerated incidence of osteonecrosis: a systematic review and meta-analysis |
| Q34027495 | Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis |
| Q37720586 | Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study. |
| Q81577955 | Vitamin D deficiency in patients with active systemic lupus erythematosus |
| Q44680483 | Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids |
| Q81709627 | [Glucocorticoid therapy in collagen diseases diseases] |
| Q81669726 | [Secondary osteoporosis and internal medicine] |
Search more.